查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1637072

海洋胜肽的全球市场 - 全球产业分析，规模，占有率，成长，趋势，预测(2032年)

Marine Peptide Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032
出版日期: | 出版商: Fairfield Market Research | 英文 189 Pages | 商品交期: 2-5个工作天内

价格
简介目录

由于对永续生物活性化合物的需求不断增加，海洋胜肽市场有望经历显着增长。源自海洋生物的海洋胜肽因其健康益处而广受认可，并可应用于食品、化妆品和药品等多个行业。这些胜肽作为免疫调节剂、抗氧化剂和抗发炎剂，正在成为全球健康运动的重要组成部分。

海洋胜肽市场预计将大幅成长，预计 2025 年市场价值将达到 3.5095 亿美元，2032 年将达到 5.4179 亿美元，预测期内复合年增长率稳定在 6.40%。萃取技术的创新和对海洋胜肽健康益处的认识不断提高是推动这一增长的关键因素。此外，人们对营养补充品和功能性产品的日益偏好也支持了市场扩张。

海洋胜肽因其防紫外线、抗衰老和卓越的保湿效果而越来越受欢迎。随着海洋胜肽在非侵入性治疗和真皮填充剂中的应用，它正在成为传统美容手术的首选替代品。越来越多的消费者正在寻求富含海洋胜肽的功能性食品和膳食补充剂来增强健康。随着这些胜肽被纳入膳食补充剂中，它们变得越来越受欢迎。提取高品质海洋胜肽的方法得到改进，降低了生产效率低下，为更广泛的工业应用打开了大门。

本报告提供全球海洋胜肽市场相关调查，提供市场概要，以及各产品类型，各最终用途，及各地区趋势，及市场参与市场企业的竞争趋势等资讯。

目录

第1章 摘要整理

第2章 市场概要

  • 市场定义和市场区隔
  • 市场动态
  • 价值链分析
  • 波特的五力分析
  • COVID-19影响分析
  • 乌克兰·俄罗斯纠纷的影响
  • 经济概要
  • 大环境分析

第3章 全球海洋胜肽市场预测，2019年～2032年

  • 全球海洋胜肽市场预测，各产品类型，金额(10亿美元)，2019年～2032年
  • 全球海洋胜肽市场预测，各最终用途，金额(10亿美元)，2019年～2032年
  • 全球海洋胜肽市场预测，各地区，金额(10亿美元)，2019年～2032年

第4章 北美的海洋胜肽市场预测，2019年～2032年

第5章 欧洲的海洋胜肽市场预测，2019年～2032年

第6章 亚太地区的海洋胜肽市场预测，2019年～2032年

第7章 南美的海洋胜肽市场预测，2019年～2032年

第8章 中东·非洲的海洋胜肽市场预测，2019年～2032年

第9章 竞争情形

  • 产品类型和各最终用途热图
  • 企业市场占有率分析，2025年
  • 竞争仪表板
  • 企业简介
    • Amicogen Inc.
    • Cargill Inc.
    • China Peptides
    • Darling Ingredients
    • Gelita AG
    • Guangzhou Honsea Sunshine Bio Science & Technology
    • Lapi Gelatine
    • Nippi Collagen
    • Nitta Gelatin
    • PB Gelatins or PB Leiner
    • Rousselot (Peptan)
    • Trobas Gelatine B.V.

第10章 附录

简介目录

The marine peptide market is poised for substantial growth, driven by the increasing demand for sustainable, bioactive compounds. Marine peptides, derived from marine organisms, are widely recognized for their health benefits and applications across multiple industries, including food, cosmetics, and pharmaceuticals. These peptides, used as immune modulators, antioxidants, and anti-inflammatory agents, are becoming integral to the global wellness movement.

Market Insights

The marine peptide market is anticipated to grow significantly, achieving a market value of $350.95 million by 2025 and $541.79 million by 2032, with a steady CAGR of 6.40% during the forecast period. Innovations in extraction techniques and increasing awareness about the health advantages of marine peptides are key factors driving this growth. The growing preference for nutraceuticals and functional products also supports the market's expansion.

Market Growth Drivers

  • 1. Increasing Adoption in the Cosmetics Sector: Marine peptides have become popular for their roles in UV protection, anti-aging, and superior moisturizing properties. Their application in non-invasive treatments and dermal fillers positions marine peptides as a preferred alternative to traditional cosmetic procedures.
  • 2. Rising Demand for Nutraceuticals: Consumers are increasingly turning to functional foods and dietary supplements enriched with marine peptides for improved health and wellness. The integration of these peptides into nutraceutical products has boosted their popularity.
  • 3. Advancements in Extraction Techniques: Enhanced methods for deriving high-quality marine peptides have reduced production inefficiencies, making them more accessible to a broad range of industries.

Business Opportunities

  • 1. Nutraceutical Sector Expansion: The demand for marine peptides is rising as consumers seek products addressing age-related health concerns. Marine peptide-based supplements offering essential nutrients, such as calcium and proteins, are gaining traction.
  • 2. Growing Applications in Agriculture: Marine peptides have demonstrated efficacy in improving crop performance and resilience during droughts, creating opportunities in the agricultural sector in regions like South Asia and Oceania.
  • 3. Pharmaceutical Applications: Marine peptides are increasingly used in managing blood pressure and reducing cardiac risks, opening doors for further innovation in pharmaceutical formulations.

Regional Analysis

North America: North America leads the marine peptide market, driven by a robust demand for pharmaceutical and nutraceutical applications. A surge in R&D activities, coupled with collaborations between international and regional players, bolsters market growth in the region.

South Asia & Oceania: This region is witnessing significant growth due to rising awareness about health and beauty benefits associated with marine peptides. Demand in agriculture and animal nutrition further supports market expansion.

Europe: Europe remains a critical market due to high demand for sustainable and organic cosmetic and nutraceutical products.

Market Restraints

  • 1. High Production Costs: Sophisticated extraction techniques and sustainable sourcing methods contribute to elevated production expenses, posing challenges to affordability and market scalability.
  • 2. Allergies Related to Marine Sourcing: Concerns over allergies associated with seafood-derived products limit the consumer base for marine peptides, particularly for individuals with sensitivity to marine products.

Key Players

Prominent companies in the marine peptide market include:

  • Amicogen Inc.
  • Cargill Inc.
  • China Peptides
  • Darling Ingredients
  • Gelita AG
  • Guangzhou Honsea Sunshine Bio Science & Technology
  • Lapi Gelatine
  • Nippi Collagen
  • Nitta Gelatin
  • PB Gelatins or PB Leiner
  • Rousselot (Peptan)
  • Trobas Gelatine B.V.

These companies focus on developing innovative, high-quality marine peptide products and leveraging R&D investments to expand their market presence.

Recent Developments

  • 1. New Product Launch: In January 2021, Rousselot introduced a premium marine peptide supplement, Peptan Marine, designed to enhance skincare and pharmaceutical products. This launch underscores the growing demand for sustainable and high-performance marine-derived ingredients.

Market Impact: This innovation is expected to strengthen Rousselot's position in the global market while reshaping consumer preferences for marine-sourced peptides.

Market Segmentation

By Product Type:

  • Fish Peptides
  • Shellfish Peptides
  • Seaweed Peptides
  • Sponge Peptides
  • Squid Peptides
  • Other Product Types

By End-use Applications:

  • Food and Beverages
  • Cosmetics
  • Pharmaceuticals
  • Nutraceuticals
  • Animal Feed
  • Biotechnology
  • Other End Uses

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Marine Peptide Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2025
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Marine Peptide Market Outlook, 2019 - 2032

  • 3.1. Global Marine Peptide Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 3.1.1. Key Highlights
      • 3.1.1.1. Fish peptides
      • 3.1.1.2. Shellfish peptides
      • 3.1.1.3. Seaweed peptides
      • 3.1.1.4. Sponge peptides
      • 3.1.1.5. Squid peptides
      • 3.1.1.6. Others
  • 3.2. Global Marine Peptide Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
    • 3.2.1. Key Highlights
      • 3.2.1.1. Food and Beverages
      • 3.2.1.2. Cosmetics
      • 3.2.1.3. Pharmaceuticals
      • 3.2.1.4. Nutraceuticals
      • 3.2.1.5. Animal Feed
      • 3.2.1.6. Biotechnology
      • 3.2.1.7. Others
  • 3.3. Global Marine Peptide Market Outlook, by Region, Value (US$ Bn), 2019 - 2032
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Marine Peptide Market Outlook, 2019 - 2032

  • 4.1. North America Marine Peptide Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Fish peptides
      • 4.1.1.2. Shellfish peptides
      • 4.1.1.3. Seaweed peptides
      • 4.1.1.4. Sponge peptides
      • 4.1.1.5. Squid peptides
      • 4.1.1.6. Others
  • 4.2. North America Marine Peptide Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Food and Beverages
      • 4.2.1.2. Cosmetics
      • 4.2.1.3. Pharmaceuticals
      • 4.2.1.4. Nutraceuticals
      • 4.2.1.5. Animal Feed
      • 4.2.1.6. Biotechnology
      • 4.2.1.7. Others
    • 4.2.2. BPS Analysis/Market Attractiveness Analysis
  • 4.3. North America Marine Peptide Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 4.3.1.2. Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 4.3.1.3. Canada Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 4.3.1.4. Canada Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Marine Peptide Market Outlook, 2019 - 2032

  • 5.1. Europe Marine Peptide Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Fish peptides
      • 5.1.1.2. Shellfish peptides
      • 5.1.1.3. Seaweed peptides
      • 5.1.1.4. Sponge peptides
      • 5.1.1.5. Squid peptides
      • 5.1.1.6. Others
  • 5.2. Europe Marine Peptide Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Food and Beverages
      • 5.2.1.2. Cosmetics
      • 5.2.1.3. Pharmaceuticals
      • 5.2.1.4. Nutraceuticals
      • 5.2.1.5. Animal Feed
      • 5.2.1.6. Biotechnology
      • 5.2.1.7. Others
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. Europe Marine Peptide Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.3.1.2. Germany Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 5.3.1.3. U.K. Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.3.1.4. U.K. Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 5.3.1.5. France Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.3.1.6. France Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 5.3.1.7. Italy Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.3.1.8. Italy Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 5.3.1.9. Turkey Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.3.1.10. Turkey Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 5.3.1.11. Russia Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.3.1.12. Russia Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 5.3.1.13. Rest of Europe Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.3.1.14. Rest of Europe Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Marine Peptide Market Outlook, 2019 - 2032

  • 6.1. Asia Pacific Marine Peptide Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Fish peptides
      • 6.1.1.2. Shellfish peptides
      • 6.1.1.3. Seaweed peptides
      • 6.1.1.4. Sponge peptides
      • 6.1.1.5. Squid peptides
      • 6.1.1.6. Others
  • 6.2. Asia Pacific Marine Peptide Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Food and Beverages
      • 6.2.1.2. Cosmetics
      • 6.2.1.3. Pharmaceuticals
      • 6.2.1.4. Nutraceuticals
      • 6.2.1.5. Animal Feed
      • 6.2.1.6. Biotechnology
      • 6.2.1.7. Others
    • 6.2.2. Others BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Marine Peptide Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.3.1.2. China Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 6.3.1.3. Japan Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.3.1.4. Japan Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 6.3.1.5. South Korea Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.3.1.6. South Korea Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 6.3.1.7. India Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.3.1.8. India Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 6.3.1.9. Southeast Asia Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.3.1.10. Southeast Asia Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 6.3.1.11. Rest of Asia Pacific Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.3.1.12. Rest of Asia Pacific Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Marine Peptide Market Outlook, 2019 - 2032

  • 7.1. Latin America Marine Peptide Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Fish peptides
      • 7.1.1.2. Shellfish peptides
      • 7.1.1.3. Seaweed peptides
      • 7.1.1.4. Sponge peptides
      • 7.1.1.5. Squid peptides
      • 7.1.1.6. Others
  • 7.2. Latin America Marine Peptide Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Food and Beverages
      • 7.2.1.2. Cosmetics
      • 7.2.1.3. Pharmaceuticals
      • 7.2.1.4. Nutraceuticals
      • 7.2.1.5. Animal Feed
      • 7.2.1.6. Biotechnology
      • 7.2.1.7. Others
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Marine Peptide Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 7.3.1.2. Brazil Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 7.3.1.3. Mexico Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 7.3.1.4. Mexico Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 7.3.1.5. Argentina Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 7.3.1.6. Argentina Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 7.3.1.7. Rest of Latin America Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 7.3.1.8. Rest of Latin America Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Marine Peptide Market Outlook, 2019 - 2032

  • 8.1. Middle East & Africa Marine Peptide Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Fish peptides
      • 8.1.1.2. Shellfish peptides
      • 8.1.1.3. Seaweed peptides
      • 8.1.1.4. Sponge peptides
      • 8.1.1.5. Squid peptides
      • 8.1.1.6. Others
  • 8.2. Middle East & Africa Marine Peptide Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Food and Beverages
      • 8.2.1.2. Cosmetics
      • 8.2.1.3. Pharmaceuticals
      • 8.2.1.4. Nutraceuticals
      • 8.2.1.5. Animal Feed
      • 8.2.1.6. Biotechnology
      • 8.2.1.7. Others
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Marine Peptide Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.3.1.2. GCC Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 8.3.1.3. South Africa Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.3.1.4. South Africa Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 8.3.1.5. Egypt Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.3.1.6. Egypt Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 8.3.1.7. Nigeria Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.3.1.8. Nigeria Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 8.3.1.9. Rest of Middle East & Africa Marine Peptide Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.3.1.10. Rest of Middle East & Africa Marine Peptide Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Product Type vs by End Use Application Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Amicogen Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Cargill Inc.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. China Peptides
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Darling Ingredients
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Gelita AG
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Guangzhou Honsea Sunshine Bio Science & Technology
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Lapi Gelatine
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Nippi Collagen
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Nitta Gelatin
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. PB Gelatins or PB Leiner
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. Rousselot (Peptan)
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. Trobas Gelatine B.V.
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations